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AbstrACt
Introduction  Linkage and retention in HIV medical 
care remains problematic in the USA. Extensive health 
utilisation data collection through electronic health records 
(EHR) and claims data represent new opportunities for 
scientific discovery. Big data science (BDS) is a powerful 
tool for investigating HIV care utilisation patterns. The 
South Carolina (SC) office of Revenue and Fiscal Affairs 
(RFA) data warehouse captures individual-level longitudinal 
health utilisation data for persons living with HIV (PLWH). 
The data warehouse includes EHR, claims and data from 
private institutions, housing, prisons, mental health, 
Medicare, Medicaid, State Health Plan and the department 
of health and human services. The purpose of this study 
is to describe the process for creating a comprehensive 
database of all SC PLWH, and plans for using BDS to 
explore, identify, characterise and explain new predictors 
of missed opportunities for HIV medical care utilisation.
Methods and analysis This project will create person-
level profiles guided by the Gelberg-Andersen Behavioral 
Model and describe new patterns of HIV care utilisation. 
The population for the comprehensive database comes 
from statewide HIV surveillance data (2005–2016) for 
all SC PLWH (N≈18000). Surveillance data are available 
from the state health department’s enhanced HIV/AIDS 
Reporting System (e-HARS). Additional data pulls for 
the e-HARS population will include Ryan White HIV/AIDS 
Program Service Reports, Health Sciences SC data and 
Area Health Resource Files. These data will be linked to 
the RFA data and serve as sources for traditional and 
vulnerable domain Gelberg-Anderson Behavioral Model 
variables. The project will use BDS techniques such 
as machine learning to identify new predictors of HIV 
care utilisation behaviour among PLWH, and ‘missed 
opportunities’ for re-engaging them back into care.
Ethics and dissemination The study team applied for 
data from different sources and submitted individual 
Institutional Review Board (IRB) applications to the 
University of South Carolina (USC) IRB and other local 
authorities/agencies/state departments. This study was 
approved by the USC IRB (#Pro00068124) in 2017. To 
protect the identity of the persons living with HIV (PLWH), 
researchers will only receive linked deidentified data 
from the RFA. Study findings will be disseminated at local 
community forums, community advisory group meetings, 
meetings with our state agencies, local partners and 
other key stakeholders (including PLWH, policy-makers 
and healthcare providers), presentations at academic 
conferences and through publication in peer-reviewed 
articles. Data security and patient confidentiality are 
the bedrock of this study. Extensive data agreements 
ensuring data security and patient confidentiality for the 
deidentified linked data have been established and are 
stringently adhered to. The RFA is authorised to collect and 
merge data from these different sources and to ensure 
the privacy of all PLWH. The legislatively mandated SC 
data oversight council reviewed the proposed process 
stringently before approving it. Researchers will get only 
the encrypted deidentified dataset to prevent any breach 
of privacy in the data transfer, management and analysis 
processes. In addition, established secure data governance 
rules, data encryption and encrypted predictive techniques 
will be deployed. In addition to the data anonymisation as 
a part of privacy-preserving analytics, encryption schemes 
that protect running prediction algorithms on encrypted 
data will also be deployed. Best practices and lessons 
learnt about the complex processes involved in negotiating 
and navigating multiple data sharing agreements between 
different entities are being documented for dissemination. 
strengths and limitations of this study
 ► This study is among the first in the USA to accu-
mulate individual level data from multiple sources 
for predictive model development and validation of 
health utilisation in a statewide population of per-
sons living with HIV (PLWH).
 ► This study is unique in its ability to examine health 
utilisation for all South Carolina PLWH from initial di-
agnosis across different treatment points and times 
in the HIV treatment cascade.
 ► Obtaining data release agreement, collecting and 
merging HIV sensitive data from different entities 
require significant time and effort to ensure privacy 
and confidentiality of all subjects.
 ► Although missing data or incorrect data may be a 
problem for care status classification, mandatory 
statewide reporting of HIV diagnosis and laboratory 
markers (CD4 and viral load) provides confidence in 
data completeness.
 ► Machine learning techniques could yield a several 
combinations of factors that could be difficult to in-
terpret, but in anticipation of this problem, we have 
constituted a clinician expert review panel, and plan 
to use chart abstractions for further validation.
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IntroduCtIon
Ending the HIV epidemic requires focus on ‘treatment 
as prevention’ as a goal. Prevention through linkage 
and retention in HIV medical care are key objectives of 
Healthy People 2020 and National HIV/AIDS Strategy.1 2 
Advances in HIV medications have made living a healthy 
life possible for persons living with HIV (PLWH), with 
well-established associations between linkage to/retention 
in HIV medical care and viral load (VL) suppression.3–17 
Recent numbers and proportions of South Carolina (SC) 
PLWH engaged in each step of the HIV treatment cascade 
show that cumulatively, only 66% received any medical 
care, and of these, only 54% received continuous HIV 
medical care.18 Similarly, national estimates show that 
42%–59% of patients with HIV are not in HIV medical 
care.4 12 19 
Health inequities persist in the HIV treatment cascade 
for PLWH in SC.20 These health inequities are important 
since a lack of engagement and retention in HIV medical 
care increases the likelihood of HIV transmission due 
to poor VL suppression.3–14 16 17 Neither access to health 
insurance nor early linkage to care have thus far predicted 
retention in and consistent use of HIV medical care. This 
study proposes using both statistical and machine learning 
techniques to identify new and important predictors of 
HIV cascade treatment outcomes for PLWH, that is, CD4 
and VL.
A responsive healthcare system must engage all PLWH 
at all stages of the HIV treatment cascade from HIV 
testing, linkage to care, timely initiation of care, retention 
in care and adherence to antiretroviral treatment (ART) 
with repeated CD4/viral load (VL) testing. Adoption of 
electronic health records (EHR), combined with the use 
of big data science (BDS) techniques provides an oppor-
tunity to improve health outcomes and manage high-risk 
and high-cost PLWH.21–24 This study will create a compre-
hensive dataset accumulated from multiple sources, and 
use innovative BDS techniques to analyse new and old 
predictors of retention in HIV medical care. General 
health utilisation behaviour pre-HIV diagnosis will be 
studied to identify where missed opportunities for HIV 
testing occurs. PLWH profiles based on HIV medical care 
seeking behaviour will be developed with concomitant 
identification of gaps in HIV care and missed opportu-
nities. The resulting model from this study will be used 
by the State Department of Health and Environmental 
Control (DHEC) to improve HIV care, through indi-
vidual targeted linkage to, and retention in care. This 
study extends beyond the traditional scope of most HIV 
research in proposing novel machine learning processes 
for developing and validating a model of HIV medical 
care utilisation. In this protocol, we describe the process 
for acquiring datasets, data linkages and methods we will 
use to establish a population cohort from 2005 to 2016. 
Linkage of different datasets at the individual level using 
unique identifiers (IDs) at the population level enables us 
to achieve the following specific aims:
1. Use five commonly used measures of retention (de-
scribed elsewhere) in HIV care25 to generate a profile 
and pattern of care-seeking behaviour for SC PLWHs.
2. Use data mining and predictive analytics to identify 
missed opportunities for HIV testing prior to HIV di-
agnoses for SC PLWHs using CD4 count/VL as labora-
tory-based markers of time.
3. Identify gaps in the treatment cascade for all SC PLWHs 
who were never in care, not in care or who transition 
in and out of care compared with those consistently in 
HIV medical care.
4. Develop and validate a predictive risk model useful 
for targeting HIV care linkage interventions to all SC 
PLWHs who are never in care, not in care, transition 
in and out of care and at risk for dropping out of care.
Purpose
The purpose of this study is to describe the framework 
and process for creating a comprehensive database of all 
SC PLWH and plans for using BDS to explore, identify, 
characterise and explain new predictors of missed oppor-
tunities for HIV medical care utilisation. Study findings 
will be integrated with ongoing efforts of the SC DHEC’s 
Data-to-Care (DTC) Program, and the Ryan White Care 
Program to link and retain PLWH in care.
MEthods And AnAlysIs
This project is a population cohort-based study aimed at 
improving HIV treatment for all SC PLWH. Analytic focus 
will be on classification to predict where missed oppor-
tunities occur, gap identification and utilisation manage-
ment across the HIV treatment cascade. We will classify 
the PLWH to four care groups: (1) never in care, (2) tran-
sitioning in and out of care, (3) not in care and (4) consis-
tently in care using CD4/VL laboratory biomarkers and 
other demographics. An investigation into why certain 
health utilisation behaviours occur within the care group 
will be done using segmentation analysis. We will use 
predictive data mining to score newly identified variables 
representing the probability of the individual behaviour 
(action) occurring in the future (in this case HIV medical 
care utilisation).26–28 Findings will be validated through 
a triangulated process involving the use of a HIV clini-
cian expert panel, chart abstraction review process and 
through the ‘DTC’ community advisory board to explain 
and interpret new patterns/characteristics.
Guiding conceptual framework
This study is informed by an adaptation of the Gelberg-An-
dersen Behavioral Model framework.11 26 This model 
identifies factors affecting health services utilisation 
among vulnerable patient populations and measures 
domains relevant for elucidating health utilisation 
patterns.29 30 Socioecological factors affecting engage-
ment in HIV medical care model will help guide the inter-
pretation of new clusters of predictors.12 Studies have 
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identified factors referred to in both models as important 
to PLWH.18 19 31–36
study area and population
This study will be conducted in SC located in the south-
eastern region of the USA, with a population of 4 961 119 
in 2016.37 Current epidemiological profile shows the 
PLWH ((n=18998) as mostly African-American [69%], 
men (71%) and aged 30–49 years (41%)).38
data sources
The proposed data linkage is complex, and the compre-
hensive dataset is large. To our knowledge, no such data 
have ever been linked to study HIV treatment outcomes 
at the population level in the USA. Novel application of 
BDS techniques using a population of PLWHs can break 
new grounds and provide additional tools for improving 
care outcomes through the estimation of individual risks. 
Data sources are described in greater detail below.
sC office of revenue and Fiscal Affairs (rFA) Integrated data 
system
RFA collects individual health utilisation data based 
on state laws requiring mandatory data reporting. The 
state law Section 44-6-170 guides the RFA in collecting 
and releasing healthcare related data. Since 1996, the 
RFA receives reports on all diagnoses from emergency 
departments, hospital inpatient, ambulatory care and 
outpatient surgery facilities in the Uniform Billing form 
(UB-92) format.39 Non-compliant facilities face stiff penal-
ties which increases compliance. At the RFA, individual 
patient information will be linked using unique patient 
IDs such as name, birth date and social security number.
The RFA’s integrated data structure is recognised as a 
great example of an integrated data system in the USA 
(figure 1).40 Data from RFA includes, but are not limited 
to:
1. All payer healthcare inpatient database.
2. Medicaid services claims data (including demographic 
file, visits file and pharmacy file).
3. State Employee Health Services Plan data.
4. Department of Corrections data (crime rates, prison 
history, etc).
5. Department of Mental Health.
dhEC e-hArs and ryan White rsr data
Confidential name-based reporting of HIV/AIDS in SC 
as a reportable disease began in February 1986 leading to 
the creation of DHEC’s enhanced HIV/AIDS reporting 
system (e-HARS).39 41 e-HARS is a laboratory-based 
reporting system to which all statewide CD4 and VL tests 
are reported since 1 January 2004 as mandated by the 
Code of Laws of SC Section 44-29-10: Regulation 61-20.39 41 
e-HARS is a collection of computer programs and data 
files developed by the Centers for Disease Control and 
Prevention to simplify the management and analysis of 
HIV/AIDS surveillance data. DHEC also provides linkage 
to Ryan White Care clinic data through the Ryan White 
HIV/AIDS Program Service Reports (RSR). The annual 
RSR captures information regarding the services provided 
by all Ryan White-funded entities.42
health sciences south Carolina (hssC) data
HSSC is a biomedical research collaborative consisting 
of six of the state’s largest health systems namely the 
Figure 1 South Carolina Office of Revenue and Fiscal Affairs Integrated Data System.
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Greenville Hospital System, University Medical Center, 
Palmetto Health, Spartanburg Regional Healthcare 
System, McLeod Health, AnMed Health and Self Regional 
Healthcare and the state’s largest research-intensive 
universities Clemson University, the Medical University 
of SC and the University of SC. HSSC clinical data ware-
house includes a Master Patient Index from multiple 
health systems that allows for the matching of clinical 
records across disparate information systems for a single 
patient.
Area health resources File (AhrF) and census tract data
The AHRF is a public dataset made available by Health 
Resources and Services Administration which contains 
data on healthcare professions, hospitals and health-
care facilities and US census population data. The AHRF 
provides health system-level information in areas such as 
healthcare professions, health facilities, hospital utilisa-
tion, expenditure and environment. Additional data on 
education, poverty, median income, employment, and so 
on, for different areas in SC will be extracted from the 
American Community Survey data.
data linkage, release and security
RFA operations are guided by the SC data oversight council 
(DOC) as mandated by the state legislative assembly. The 
DOC oversees and regulates the collection and release of 
healthcare data in approved formats based on prevailing 
privacy laws. Data elements, which, when linked to other 
databases, can directly or indirectly identify a patient/
healthcare professional, health insurer or healthcare 
facility are restricted. Protected health information such 
as patient name, address and social security numbers 
are never releasable; however, the RFA will use them to 
conduct final data linkages. The RFA will act as the honest 
data broker, deidentify the data and create unique IDs 
useful for research purposes. Table 1 demonstrates the 
extent of data linkage and highlights connections across 
different data sources. Detailed data release agreements 
are required and were secured from each data source 
before linkage. As a result of the scope and complexity 
of the data linkage, the state health department (DHEC) 
and the RFA created an intra-agency data sharing agree-
ment to guide the data sharing process between both 
agencies. This intra-agency agreement provided specific 
terms and rules for data linkage to ensure confidenti-
ality. In addition, SC Medicaid, departments of mental 
health, social services and corrections carefully reviewed 
the proposed data linkage to ensure stringent adherence 
to patient confidentiality. During data linkage, the RFA 
retained the right to create new variables in lieu of vari-
ables that could remotely identify any individual. Two 
examples are described here. First, the RFA scrambled 
the dates by introducing a modifier known only to them, 
while maintaining the original time between each date. 
This made it impossible for researchers to identify PLWH 
based on dates of service. In another example, rather than 
releasing spatial identifying data like zip codes or census 
block information, the RFA created the needed variables 
for the study, after carefully assessing the demand for the 
information. So instead of researchers receiving zip code 
data to calculate individual distance travelled for care, 
the RFA computed the distance travelled and included 
it in the final dataset as a computed variable. This work-
around ensured that while the researchers did not get the 
zip code information, they still received the measure of 
interest (distance travelled to/from facility) computed by 
the RFA. A similar approach was deployed for all poten-
tial identifiable patient information. The state health 
department (DHEC) and the RFA hold the keys to the 
unique IDs created during the linkage. This will enable 
them to apply the models and algorithms created during 
the study, to individualised PLWH interventions in the 
future. All data transfers occur using secure file transfer 
protocols. Data are received from sources fully encrypted 
and stored fully encrypted with encryption software. The 
data are stored in a key-access only facility hosting servers. 
Network shares for users are created via a distributed 
file system and user access is controlled via user groups 
containing unique IDs that require complex passwords 
on facility site.
Population inclusion criteria
Only living PLWH whose residence at diagnosis was SC 
are included in the study. A key question when describing 
PLWH not in HIV medical care is outmigration. Census 
estimates show a positive net immigration trend for SC, 
and so we do not expect any problem.43 Nevertheless, 
we will scrutinise the data carefully to interpret our data 
appropriately in case migration becomes an issue. Only 
cases with age ≥13 in the diagnosed prevalence year are 
included in the analysis (ie, age must be ≥13 in 2005 to 
be included in analysis). We chose 2005 since this was the 
year after the state law mandatory reporting of all CD4 
and VL tests to e-HARS began. Twelve years (2005–2016) 
of HIV utilisation data is available for this study.
hIV MEdICAl CArE PAttErns And GElbErG-AndErsEn 
ModEl VArIAblEs
Gelberg-Andersen Model variables
Predisposing, enabling and need factors correspond to 
the wide array of HIV data associated with linkage to care, 
retention, re-engagement and ART monitoring in the 
HIV treatment cascade. Variables reflecting Gelberg-An-
dersen Model along with their corresponding stages 
along the HIV treatment cascade and their data sources 
are illustrated in figure 2. Focus will be placed on cate-
gorising variables under the appropriate factor predictive 
of their HIV medical care utilisation. These variables are 
available from the previously described data sources.
Detailed examples of specific Gelberg-Anderson predis-
posing variables available through the e-HARS database 
include patient name, birth date, social security number 
(restricted data elements for linkage only), date of first 
positive HIV test, AIDS diagnosis date, source of report 
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Table 1 HIV treatment cascade and corresponding variables data sources*†  
HIV treatment cascade Variables based on Gelberg-Andersen Model Data sources
Diagnosis Level at diagnosis
 ► CD4
 ► Viral load
Department of Health and Environmental 
Control Enhanced HIV/AIDS Reporting System 
(DHEC e-HARS)
Predisposing factors
HIV linkage to care
Retention
Re-engagement
Demographics Revenue and Fiscal Affairs (RFA)
Medicaid
DHEC e-HARS
Health beliefs
Vulnerable domains
Location
RFA
American Community Survey (ACS) Census 
Tract
Criminal behaviour, violent status Department of Corrections
Mental Illness Department of Mental Health
Childhood characteristics Department of Social Services (DSS)
Enabling factors
Regular source of care Medicaid
RFA
Ryan White Service Reports (RSR)
Social support, public benefits DSS
RSR
Health services resources ACS Census Tract
CDC GPS data
RFA
Area Health Resource Files (AHRF)
Palmetto Health Hospital data
Greenville Health System data
Case management DHEC e-HARS
RSR
Community resources ACS Census Tract
Location variables (poverty, education, median 
income, employment)
ACS Census Tract
Need factors
Evaluated health—diagnosis, comorbidities RFA
Perceived health RSR
Health behaviours
Personal health practices RFA
Health Sciences South Carolina (HSSC)
DHEC e-HARS
RSR
ART monitoring Use of health services
(HIV test dates, AIDS diagnosis dates)
RFA
HSSC
Palmetto Health Hospital data
Greenville Health System data
DHEC e-HARS
Continued
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and transmission risk factor. Others include gender, race/
ethnicity, county of residence, year of death, cause of death 
(International Classification of Diseases (ICD)-9, ICD-10 
codes), poverty, education, median income, employ-
ment, and so on, all CD4 +T cell counts and VL values. 
Vulnerable predisposing domain variables, such as crim-
inal behaviour, violent status, mental illness, and child-
hood characteristics, are provided through RFA data 
sources. Enabling factors such as regular source of care 
will be obtained from Medicaid/State Healthcare plan. 
Data related to social support and public benefits will be 
obtained from RSR through medical case management 
and RFA. Need factor variables will be obtained through 
inpatient claims data from HSSC and RFA. The inpatient 
data include patient demographics, source and type of 
admission, visits/encounters, diagnoses, procedures, 
laboratory results and length of stay. For HIV utilisation 
outcomes data, e-HARS will provide CD4 and VL measures 
as predictors of retention in care. The core variables for 
HIV utilisation, for example, missed visits, appointment 
adherence, constancy in 3-month or 4-month, 6-month 
interval (retention in care variables) are described in 
table 2. We will define visits/health encounters that lead 
care providers to suggest HIV testing, that is, to persons 
belonging to a high-risk group for HIV acquisition and 
who presented with HIV-related or non-HIV-related clin-
ical conditions.
Antiretroviral medication and polypharmacy
EHR from patient encounters available through the RFA 
and HSSC capturing information about PLWH health-
care service utilisation and medications will be analysed 
during the study. EHR data from the RFA contain infor-
mation related to encounter visits, diagnosis, laboratory 
services and medications (number prescribed, drug class, 
indication, strength and dosage). Binary variables will be 
created for ART status.
data analysis plan
Data management, cleaning and mining
Data will be assessed for reliability to deal with issues 
related to missing, aberrant or extreme values. New 
variables and data inclusion criteria in each aim will be 
validated through chart review, HIV clinicians’ expert 
panel and the DTC community advisory board.26–28 We 
will reduce the dimension of the variables (number 
of variables) using autocorrelation, multicollinearity 
and principal component analysis as guided. The focus 
during data management will be on eliminating extreme 
outliers, and excluding irrelevant variables and discre-
tising (binning) continuous variables. Appropriate 
methods will be deployed to prepare for classification and 
prediction.
Population segmentation
To achieve specific aim #1, supervised and unsupervised 
machine learning will be used to identify care patterns or 
HIV utilisation. Once an individual is assigned to a certain 
care group, it is necessary to discover a pattern that may 
lead them to this care group. Thus, we will try to classify 
them based on the individual and system factors that lead 
the recognition of the care group. Many classification 
tools are available in machine learning: logistic regres-
sion, naive Bayes classifier, support vector machine and 
random forest. Most can be implemented in R. Different 
distance methods (eg, Jaccard or Gower) will be deployed 
to measure similarities between HIV utilisation. Once the 
distance between variable is correctly measured, the clus-
tering method, a method of unsupervised learning, will 
be operated over a distance matrix instead of the original 
data matrix. Both the K-means clustering and partitioning 
around medoids algorithms (PAM) will be applied to 
classify the data into ‘k’ groups.26–28 40 For example, we 
will use cluster analysis to partition the health utilisation 
data into groups of similar health utilisation behaviour. 
Derived clusters will be interpretable based on relevant 
Gelberg-Andersen variables and as such can be assigned a 
description/class label. The result of a cluster analysis is a 
binary tree, or dendrogram, with n–1 nodes. We propose 
using tree pruning to adjust model complexity for the 
creation of an optimal model. The simplest model with 
the highest validation assessment will be considered the 
best model. Statistics for judging the model will depend 
on the type of prediction classifications, rankings or esti-
mates. For prediction estimates, the squared error (differ-
ence between target and estimate) will be used to assess 
model performance.2 26–28 40
Predictive modelling
For specific aims #2–3, we will identify the associations 
between the missed opportunities and/or treatment 
cascade, such as timing to care and consistency in care 
with Gelberg-Andersen domain inputs such as gender, 
race, sexual orientation, crime history, location, and so 
HIV treatment cascade Variables based on Gelberg-Andersen Model Data sources
Viral suppression Outcomes
Viral load
CD4 level
DHEC e-HARS
*All data linkage is conducted at the individual unit level using name, date of birth and social security number.
†All records from other datasets linked to the e-HARS cohort are available through the RFA and other data sources listed above.
ART, antiretroviral treatment; CDC, Centers for Disease Control and Prevention; GPS, Global Positioning System.
Table 1 Continued 
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on. To achieve specific aim #4, we will build and vali-
date appropriate predictive statistical models, such as 
multinomial logistic regression model, Cox proportional 
hazards model and generalised linear mixed model, to 
investigate the impact of care pattern, missed opportunity 
and Gelberg-Andersen variables to investigate how soon 
linkage to care, status in care and CD4/VL level changes. 
A HIV clinician expert panel and the DTC community 
group will provide guidance on the interpretation of 
new findings. Once the model is validated, trained and 
assessed using test data, it will be deployed and moni-
tored for performance. An overview of the analytic plan 
is illustrated in figure 3.
Model development and validation
Once the pattern is identified such as health utilisation 
pattern, variable distributions will be summarised for 
pattern status (mean, SD and counts), and compared 
using the t-test, analysis of variance test and χ2 test. Where 
test assumptions are not satisfied, non-parametric tests 
Figure 2 HIV treatment cascade including Gelberg-Andersen Model variables and data sources. 
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(Wilcoxon rank test and Kruskal-Wallis Test) will be 
applied. Results will be discussed among the investigation 
team to find the most appropriate pattern characteristic. 
Care patterns identified in aim 1 and the risk factors 
and missed opportunities identified in aim 2 will serve 
as the main exposure variables to identify the association 
between the HIV treatment cascade, HIV care patterns 
and missed opportunities. All variables in Gelberg-An-
dersen Behavioral Model, which can be identified in the 
linked dataset, will be used as the potential risk factors. 
With the patient characteristics, hospital information, care 
information and variables in Gelberg-Andersen Behav-
ioral Model, a high dimension of predictors is expected. 
Cross validation will be used to evaluate the prediction 
performance and to compare the different risks predic-
tion model. The data will be divided into training, testing 
and validation data. Potential interactions between 
variables will be examined, using the log-likelihood ratio 
test to determine statistical significance. Using machine 
learning techniques, we will create algorithms that can 
alert/flag high dropout risk PLWH. In addition, we will 
automate the algorithms to determine the best predic-
tors of re-engagement into HIV medical care based on 
historical health utilisation patterns, CD4 counts and viral 
suppression. The algorithms will be shared with DHEC 
and RFA, who will apply these algorithms to the original 
data. The algorithms will also be shared with the Ryan 
White Program for use in monitoring and retaining 
PLWH in care.
Model monitoring and validation
While the promise inherent in data mining is in discov-
ering new and useful patterns in big data, its true value is 
in responding to these patterns by acting on them. This 
Table 2 Selected variables for HIV care pattern determination*
Measure
Type of output;
calculation overview
Observation time needed 
to calculate
Missed visit Dichotomous; were there any missed visits in the interval?
Count; number of missed visits in the interval
At least 6 months
Appointment adherence Continuous; attended appointments divided by (attended 
appointments plus missed appointments)
Patient: at least 1 year; 
clinic: as short as 1 day
Constancy, 3-month or 
4-month intervals
Categorical; number of 3-month or 4-month intervals with at least one 
attended visit
At least 6–8 months
Constancy, 6-month 
intervals
Categorical; number of 6-month intervals with at least one attended 
visit
At least 1 year
Constancy, 6-month 
intervals, longer term
Dichotomous; At least one attended visit in each 6-month interval with 
at least 60 days between visits
At least 2 years
Constancy, HIV/AIDS 
Bureau
Dichotomous; At least two attended visits in 12 months, separated by 
at least 90 days
At least 1 year
Gaps Dichotomous; did the time between two contiguous attended visits 
exceed a threshold (eg, 6 months)?
At least 1 year
Continuous; what is the longest duration of time between two 
contiguous attended visits?
*Definitions for visits have been previously described elsewhere.25
Figure 3 Analytic plan.
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ultimately moves data into information, information into 
action and action into value. We anticipate developing 2–3 
predictive models. After predictive models are developed, 
and validated, they will be deployed against new claims 
data showing healthcare utilisation. Since we have obser-
vations for PLWH who use HIV medical care consistently 
(an identified segment/cluster), we will create a unique 
normalised score for this population and set it as the norm 
for comparison. Profiles and predictors of care status for 
the not-in-care population will be assessed by the models 
deployed against new claims data (2017–2018). Model 
scores will be assessed to evaluate model performance 
and accuracy using a propensity score analysis.2 26–28 40 
Findings will be reviewed by the HIV clinician’s expert 
panel as well as the DTC advisory group. They will help 
inform the identification of new variables and predictors 
by cross validating them based on abstracted charts. Vali-
dation rules will be established to guide this process.19 
Algorithms for the model will be created and embedded 
with DHEC’s HIV surveillance system and Ryan White 
Program. Qualified state personnel will use this informa-
tion to identify/flag those at risk for dropping out of care, 
those out of care and those not likely to engage in care 
after linkage. The goal in doing this is to help provide 
targeted assistance to such high-risk individuals. The algo-
rithms will be reviewed intermittently based on the avail-
ability of new data to ensure good performance.
Patient involvement
Patients were not involved in preparing this study 
protocol.
dIsCussIon
The linkage of several databases capturing traditional 
clinical outcomes through the EHR and other health 
claims-based system, integrated to a social determinants 
of health data system under the purview of this study, 
holds significant promise for HIV medical care. Prior 
to this study, the confidential nature of HIV has limited 
translational research across the HIV treatment cascade 
to either clinical or social determinants studies, but rarely 
both. The challenges with finding such data sources are 
significant, as is the ability to measure variables at the 
individual level. BDS techniques offer the potential of 
opening new possibilities for managing complex health 
conditions like HIV.43 The robust value inherent in using 
population-based cohorts for improving health outcomes 
and predicting future health utilisation is documented.44 45 
Successful examples of previous and ongoing application 
of BDS techniques can be found in automated ECG inter-
pretation, automated detection of lung nodules from 
X-rays, and creation of Framingham Risk Score.46 Other 
examples using unsupervised learning for pattern iden-
tification exist in the ongoing development of precision 
medicine,47–51 systolic heart failure survival prediction52 
and the use of machine learning to automate diag-
nosis of acute brain infractions.53 BDS techniques have 
successfully been applied to large-scale clinical studies 
such as the CArdiovascular disease research using LInked 
Bespoke studies and Electronic health Record study in the 
UK44 and Comparison of Medical Therapy, Pacing, and 
Defibrillation in Heart Failure (COMPANION) trials in 
the USA.45 Studies point to these examples as the future 
and real added value of BDS techniques like machine 
learning.54 The combination of machine learning tech-
niques with expert clinicians, case workers, stakeholders 
together has serious potential to improve the collective 
health of PLWH. This study is unique in its data linkage 
and population focus, giving it strengths and precision 
unavailable to previous studies using samples of PLWH 
for retention in care studies. This study also goes beyond 
prior studies by integrating both model development and 
model validation using BDS techniques and meet the 
checklists for reporting as recommended by the ‘Trans-
parent Reporting of a multivariable prediction model 
for Individual Prognosis or Diagnosis’ guidelines.55 The 
novelty in this study is the integration of traditional and 
vulnerable domain factors with large troves of EHR data, 
and its tieback to actual linkage and retention in care. 
The state department of health (DHEC) surveillance 
programme, and Ryan White Program will be strength-
ened with the ability to flag PLWH at risk for not engaging 
in care after linkage, or those at risk at dropping out of 
care. This study plans to automate a process that had been 
previously manually done. It also improves the process by 
flagging individuals at high risk for not engaging in or 
dropping out of care for intervention. In addition, loca-
tions/providers where missed opportunities for HIV care 
re-engagement occurred will also receive strengthening 
to improve patient engagement. DHEC’s legal mandates 
allow them to work closely with clinical providers in 
targeting individualised interventions to such at-risk 
PLWH. This will help improve engagement in, and future 
retention in care among PLWH.
Future improvement and application of the model
Plans for model improvement using future population 
HIV care utilisation data will improve model perfor-
mance and external validation as we focus on evalu-
ating the incremental value of specific predictors (new 
and old) for HIV care utilisation. Future data will be 
deployed to the models for model maintenance and 
improvement. The use of the health system by PLWH not 
in care represents missed opportunities for re-engaging 
them into HIV medical care. Without treatment as a 
form of prevention, ending the HIV epidemic is harder 
to achieve. Benefits from advances in HIV treatment are 
also lost for those not in care. However, investigating 
characteristics for those who are not in care is difficult 
and expensive for health departments. The application 
of BDS to this process will make substantive improve-
ments, and allow clinicians, social workers and other 
stakeholders help re-engage this hard to reach popula-
tion back into care.
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